Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29387054 | 0.76 | KDM4E (0.39) | OXTRKDM4EPKMGAAMAPT | |
| SCHEMBL251287 | 0.76 | KDM4E (0.39) | OXTRKDM4EPKMGAAMAPT | |
| SCHEMBL18573347 | 0.76 | GAA (0.33) | OXTRKDM4EPKMGAAMAPT | |
| Ammonia Solution, Strong SCHEMBL7086115 | 0.74 | KDM4E (0.38) | OXTRKDM4EPKMGAAMAPT | |
| SCHEMBL19326887 | 0.73 | GAA (0.35) | GAAMAPT | |
| SCHEMBL5574452 | 0.73 | KDM4E (0.37) | OXTRKDM4EPKM | |
| SCHEMBL18243668 | 0.73 | OXTR (0.33) | OXTRKDM4EPKMGAAMAPT | |
| SCHEMBL8861340 | 0.73 | OXTR (0.33) | OXTRKDM4EPKMGAAMAPT | |
| Fluoride SCHEMBL1130944 | 0.73 | OXTR (0.33) | OXTRKDM4EPKMGAAMAPT | |
| SCHEMBL5090884 | 0.73 | OXTR (0.33) | OXTRKDM4EPKMGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | PCBP1, SOD1, PCLAF | OXTR 4407/4885KDM4E 2644/4885PKM 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.